Ivermectin as a potential treatment for mild to moderate COVID-19: A double blind randomized placebo-controlled trial
Ravikirti et al., Journal of Pharmacy & Pharmaceutical Sciences, doi:10.18433/jpps32105
https://c19ivm.org/ravikirti.html